<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-4500</journal-id>
<journal-title><![CDATA[Avances en Enfermería]]></journal-title>
<abbrev-journal-title><![CDATA[av.enferm.]]></abbrev-journal-title>
<issn>0121-4500</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-45002020000300369</article-id>
<article-id pub-id-type="doi">10.15446/av.enferm.v38n3.80713</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Psicodélicos y muerte digna. Uso de sustancias psicodélicas al final de la vida]]></article-title>
<article-title xml:lang="pt"><![CDATA[Psicodélicos e morte digna. O uso de psicodélicos no final da vida]]></article-title>
<article-title xml:lang="en"><![CDATA[Psychedelics and dignified death. Use of psychedelic substances at the end of life]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vinasco Barco]]></surname>
<given-names><![CDATA[Jaime Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Fundació Josep Maria Fericgla  ]]></institution>
<addr-line><![CDATA[Tordera Catalunya]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>38</volume>
<numero>3</numero>
<fpage>369</fpage>
<lpage>379</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-45002020000300369&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-45002020000300369&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-45002020000300369&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Repensar el potencial de los psicodélicos para la construcción de un marco psicoespiritual al final de la vida.  Síntesis del contenido: Con las recientes investigaciones que reconfirman el potencial de los psicodélicos para lograr experiencias místicas, estáticas y de trascendencia, los diferentes enfoques de atención al paciente moribundo se están enfrentando a una resurgente y revalidada terapia psicodélica y a un emergente paradigma psicoespiritual que procura una muerte digna, atendiendo trastornos psicológicos del final de la vida como la ansiedad, la depresión e incluso el miedo a la misma muerte. La terapia con psicodélicos favorece la construcción de un marco psicoespiritual en el moribundo, el cual está asociado a una mejor protección contra la depresión, la desesperanza, la desmoralización e incluso el deseo de una muerte acelerada.  Conclusiones: Entre las variables del marco de una muerte digna destaca la autonomía que tiene el moribundo para elegir qué hacer o no hacer con su cuerpo, su enfermedad o el final de su vida. Aquí se expone la necesidad de considerar el uso de psicodélicos para ayudar al moribundo a afrontar su deceso con paz, coraje y, sobre todo, dignidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo: Repensar o potencial do uso de psicodélicos para a construção de uma estrutura psicoespiritual no final da vida.  Síntese de conteúdo: Com as pesquisas mais recentes que confirmam o potencial do uso de psicodélicos para atingir experiências místicas, estáticas e transcendentais, as diferentes abordagens para o cuidado do paciente moribundo trazem uma ressurgente e revalidada terapia com o uso de psicodélicos e um paradigma psicoespiritual emergente que procura uma morte digna, atendendo transtornos psicológicos no final da vida como a ansiedade, a depressão e, inclusive, o medo da própria morte. Essa terapia favorece a construção de uma estrutura psicoespiritual no paciente moribundo que está ligada a uma melhor proteção contra a depressão, a perda da esperança, a desmoralização e até o desejo de uma morte acelerada.  Conclusões: Entre as variáveis no contexto de uma morte digna destaca-se a autonomia do moribundo para eleger o que fazer ou não com seu corpo, com a doença e com o final da vida. Neste trabalho, é exposta a necessidade de considerar o uso de psicodélicos para ajudar o moribundo a encarar sua morte em paz, coragem e, principalmente, com dignidade.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To rethink the potential of psychedelics for the construction of a psycho-spiritual framework at the end of life.  Content synthesis: With the recent studies that re-confirm the potential of psychedelics to get mystical, static and transcendent experiences, the different approaches to attention at dying patients are facing a resurgent and revalidated psychedelic therapy and an emerging psycho-spiritual paradigm that seeks a dignified death, attending psychological end-of-life disorders such as anxiety, depression and even fear of death itself. Psychedelic therapy favors the construction of a psycho-spiritual framework in the dying person, which is associated with a better protection against depression, despair, demoralization, and even the desire for an accelerated death.  Conclusions: The autonomy of the dying person to choose what to do or not to do with his body, illness or the end of his life is a prominent issue among the variables in the framework of a dignified death. This work exposes the need to consider the use of psychedelics in order to help the dying patient face their decease with peace, courage and, above all, dignity.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Psicodélicos]]></kwd>
<kwd lng="es"><![CDATA[Derecho a Morir]]></kwd>
<kwd lng="es"><![CDATA[Actitud Frente a la Muerte]]></kwd>
<kwd lng="es"><![CDATA[Salud Mental]]></kwd>
<kwd lng="es"><![CDATA[Espiritualidad (fuente: DeCS, BIREME)]]></kwd>
<kwd lng="pt"><![CDATA[Psicodélicos]]></kwd>
<kwd lng="pt"><![CDATA[Direito de Morrer]]></kwd>
<kwd lng="pt"><![CDATA[Atitude ante a Morte]]></kwd>
<kwd lng="pt"><![CDATA[Saúde Mental, Espiritualidade (fonte: Dees, BIREME)]]></kwd>
<kwd lng="en"><![CDATA[Psychedelics]]></kwd>
<kwd lng="en"><![CDATA[Right to Die]]></kwd>
<kwd lng="en"><![CDATA[Attitude to Death]]></kwd>
<kwd lng="en"><![CDATA[Mental Health]]></kwd>
<kwd lng="en"><![CDATA[Spirituality (source: DeCS, BIREME)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>(1)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grob]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Bossis]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Griffiths]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of the classic hallucinogen psilocybin for treatment of existential distress associated with cancer]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Carr]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Steel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychological Aspects of Cancer]]></source>
<year>2013</year>
<page-range>291-308</page-range><publisher-loc><![CDATA[Boston ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>(2)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grof]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prólogo]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Puente]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Investigación y psicoterapia psicodélica: pasado, presente y futuro]]></source>
<year>2017</year>
<edition>1</edition>
<page-range>XI-X</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[La Liebre de Marzo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>(3)</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shafiekhani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mirjalili]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vazin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychotropic drug therapy in patients in the intensive care unit-usage, adverse effects, and drug interactions: A review]]></source>
<year>2018</year>
<volume>14</volume>
<page-range>1799-812</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>(4)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Templer]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Arikawa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gariety]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychotropic drugs in terminally ill patients: A review of the clinical and research literature]]></article-title>
<source><![CDATA[Omega (Westport)]]></source>
<year>2004</year>
<volume>49</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>249-74</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>(5)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camí]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Farré]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacología de los alucinógenos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[San]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Alucinógenos: la experiencia psicodélica]]></source>
<year>1996</year>
<page-range>11-28</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Ediciones en Neurociencias]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>(6)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Timmermann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos]]></article-title>
<source><![CDATA[Rev Chil Neuro-Psiquiat]]></source>
<year>2014</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-102</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>(7)</label><nlm-citation citation-type="book">
<source><![CDATA[Diccionario Etimológico Español en Línea]]></source>
<year>2019</year>
<publisher-name><![CDATA[Eti]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>(8)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[HD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La psilocibina: perspectiva histórica y farmacológica e investigaciones actuales autorizadas]]></article-title>
<source><![CDATA[Cult Drog]]></source>
<year>2009</year>
<volume>14</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>165-88</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>(9)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samorini]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapie psichedeliche, una storia inedita italiana]]></article-title>
<source><![CDATA[Dolce Vita]]></source>
<year>2018</year>
<volume>78</volume>
<page-range>104-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>(10)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Griffiths]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Richards]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McCann]]></surname>
<given-names><![CDATA[UD]]></given-names>
</name>
<name>
<surname><![CDATA[Jesse]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later]]></article-title>
<source><![CDATA[J Psychopharmacol]]></source>
<year>2008</year>
<volume>22</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>621-32</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>(11)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gasser]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Holstein]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Michel]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Doblin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yazar-Klosinski]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Passie]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases]]></article-title>
<source><![CDATA[J Nerv Ment Dis]]></source>
<year>2014</year>
<volume>7</volume>
<page-range>513-20</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>(12)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Breitbart]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenfeld]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pessin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Poppito]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meaning-centered group psychotherapy for patients with advanced cancer: A pilot randomized controlled trial]]></article-title>
<source><![CDATA[Psychooncology]]></source>
<year>2010</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>(13)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frankl]]></surname>
<given-names><![CDATA[VF.]]></given-names>
</name>
</person-group>
<source><![CDATA[The will to meaning: Foundations and applications of logotherapy]]></source>
<year>1988</year>
<edition>1.</edition>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[Penguin]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>(14)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winkelman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of psilocybin in patients with advanced cancer and existential anxiety]]></article-title>
<source><![CDATA[Psychedelic medicine: New evidence for hallucinogenic substances as treatments]]></source>
<year>2007</year>
<page-range>205-16</page-range><publisher-loc><![CDATA[Westport ]]></publisher-loc>
<publisher-name><![CDATA[Praeger]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>(15)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Simian]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La enfermería y la investigación]]></article-title>
<source><![CDATA[Rev. Med. Clin. Las Condes]]></source>
<year>2018</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>301-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>(16)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garduño]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[GO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ortotanasia: un enfoque de atención al niño con enfermedad terminal]]></article-title>
<source><![CDATA[Cuad Bioét]]></source>
<year>1996</year>
<volume>3</volume>
<page-range>329-38</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>(17)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batista]]></surname>
<given-names><![CDATA[SJC]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CJM]]></given-names>
</name>
<name>
<surname><![CDATA[Assis]]></surname>
<given-names><![CDATA[BJK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ortotanasia en las unidades de cuidados intensivos: percepciones de los enfermos]]></article-title>
<source><![CDATA[Rev Bioét]]></source>
<year>2017</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>158-67</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>(18)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fericgla]]></surname>
<given-names><![CDATA[JM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Antropología del morir y de la muerte en Occidente. En: Arráez V; Pau M. La muerte y el morir]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Escola de Vida, Valores]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>(19)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grimberg]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[VIH/Sida y proceso salud-enfermedad-atención: construcción social y relaciones de hegemonía. En: Seminario taller de capacitación de formadores]]></source>
<year>1992</year>
<page-range>24-31</page-range><publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Lusida]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>(20)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[EL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desaparición, resignificación o nuevos desarrollos de lazos y rituales sociales]]></article-title>
<source><![CDATA[Relaciones]]></source>
<year>2006</year>
<volume>27</volume>
<numero>107</numero>
<issue>107</issue>
<page-range>147-78</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>(21)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prost]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La vida privada en el siglo XX]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Ariès]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Duby]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Historia de la vida privada]]></source>
<year>1991</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Altea, Taurus, Alfaguara]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>(22)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blackman]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Despedidas elegantes. Como mueren los grandes seres]]></source>
<year>2012</year>
<edition>2</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Liebre de Marzo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>(23)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burkert]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Cultos mistéricos antiguos]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Trotta]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>(24)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[AHR]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prácticas de ortotanasia y cuidados paliativos en pacientes con cáncer terminal: una revisión sistemática de la literatura]]></article-title>
<source><![CDATA[Enferm Glob]]></source>
<year>2018</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>529-44</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>(25)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saunders]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Velad conmigo: inspiración para una vida en cuidados paliativos]]></source>
<year>2011</year>
<edition>1</edition>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[La Caixa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>(26)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saunders]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spiritual pain]]></article-title>
<source><![CDATA[Palliat Care]]></source>
<year>1988</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>29-32</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>(27)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fericgla]]></surname>
<given-names><![CDATA[JM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ayahuasca la realidad detrás de la realidad]]></source>
<year>2018</year>
<edition>1</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Kairós]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<label>(28)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johansen]]></surname>
<given-names><![CDATA[PØ]]></given-names>
</name>
<name>
<surname><![CDATA[Krebs]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychedelics not linked to mental health problems or suicidal behavior: A population study]]></article-title>
<source><![CDATA[J Psychopharmacol]]></source>
<year>2015</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>270-9</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>(29)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hendricks]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Thorne]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Coombs]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[M W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population]]></article-title>
<source><![CDATA[J Psychopharmacol]]></source>
<year>2015</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>280-8</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>(30)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Argento]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Strathdee]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Tupper]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Braschel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shannon]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalized women in a Canadian setting]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2017</year>
<volume>7</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>(31)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grof]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psicoterapia con LSD. El potencial curativo de la medicina psiquedelica]]></source>
<year>2005</year>
<edition>1</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[La Liebre de Marzo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>(32)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nichols]]></surname>
<given-names><![CDATA[DE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychedelics]]></article-title>
<source><![CDATA[Pharmacol Rev]]></source>
<year>2016</year>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>264-355</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>(33)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[LTL]]></given-names>
</name>
<name>
<surname><![CDATA[Banazeski]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Eisele]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[De Souza]]></surname>
<given-names><![CDATA[EN]]></given-names>
</name>
<name>
<surname><![CDATA[Bitencourt]]></surname>
<given-names><![CDATA[OVJV]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La visión de la enfermería ante el proceso de muerte y morir de pacientes críticos: una revisión integradora]]></article-title>
<source><![CDATA[Enferm Glob]]></source>
<year>2016</year>
<volume>15</volume>
<numero>41</numero>
<issue>41</issue>
<page-range>322-34</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>(34)</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berazaluce]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Utilizando los criterios de la biomedicina, los antidepresivos pueden considerarse una práctica seudocientífica. Público]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B35">
<label>(35)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Masters]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Houston]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[The varieties of psychedelic experience (LSD)]]></source>
<year>1966</year>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[Holt, Rinehart &amp; Winston]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
